Article

The Globe and MailThe Globe and Mail on 2017-10-02 22:28

Growers of human heart cells, Canadian-backed biotech firm Novoheart prepares for IPO

The company grows human heart tissue from stem cells that can be used instead of lab animals for drug development

Related news